In the FOHAIC-1 study, 30% of the patients were reported to have lung metastases, but a subgroup analysis of the survival of patients with lung metastases with HAIC-FO treatment was not presented.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback